Department of Cardiology Akershus University Hospital Lørenskog Norway.
Institute of Clinical Medicine University of Oslo Norway.
J Am Heart Assoc. 2020 Oct 20;9(19):e017363. doi: 10.1161/JAHA.120.017363. Epub 2020 Sep 15.
Background Use of snus, a smokeless tobacco product, is increasing in Scandinavia. Strenuous physical activity is associated with an acute increase in high-sensitivity cardiac troponin (swhs-cTn) concentrations. Current smoking is associated with lower hs-cTn, but whether this also holds true for smokeless tobacco and whether tobacco affects the hs-cTn response to exercise remain unknown. Methods and Results We measured hs-cTnI and hs-cTnT concentrations in 914 recreational athletes before and 3 and 24 hours after a 91-km bicycle race. Self-reported snus tobacco habits were reported as noncurrent (n=796) and current (n=118). The association between snus use and change in log-transformed hs-cTnI and hs-cTnT concentrations (ie, the differences between concentrations at baseline and 3 hours and 24 hours ) were assessed by multivariable linear regression analysis. Concentrations of hs-cTn at baseline were lower in current than in noncurrent snus users (hs-cTnI median, 1.7 ng/L; Q1 to Q3: 1.6-2.3 versus 2.0 ng/L; Q1 to Q3: 1.6-3.2 [=0.020]; and hs-cTnT: median, 2.9 ng/L, Q1 to Q3: 2.9-3.5 versus 2.9 ng/L, Q1 to Q3: 2.9-4.3 [=0.021]). In fully adjusted multivariable models, use of snus was associated with lower change in hs-cTn concentrations from baseline to 3 hours (hs-cTnI: -29% [=0.002], hs-cTnT: -18% [=0.010]) and 24 hours (hscTnI: -30% [=0.010], hs-cTnT -19%, [=0.013]). Conclusions Resting hs-cTn concentrations are lower and the exercise-induced cardiac troponin response is attenuated in current users of smokeless tobacco compared with nonusers. Further insight into the pathophysiological processes underlying the attenuated cardiac troponin response to exercise in tobacco users is needed. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT02166216.
在斯堪的纳维亚,无烟烟草制品鼻烟的使用正在增加。剧烈的体力活动会导致高敏心肌肌钙蛋白(hs-cTn)浓度的急性升高。目前的吸烟与较低的 hs-cTn 有关,但这是否也适用于无烟烟草,以及烟草是否会影响运动引起的 hs-cTn 反应尚不清楚。
我们在 914 名休闲运动员进行 91 公里自行车比赛前、后 3 小时和 24 小时测量 hs-cTnI 和 hs-cTnT 浓度。自我报告的鼻烟习惯报告为非当前(n=796)和当前(n=118)。通过多变量线性回归分析评估 snus 使用与 log 转换 hs-cTnI 和 hs-cTnT 浓度变化(即基线与 3 小时和 24 小时浓度之间的差异)之间的关系。当前 snus 用户的 hs-cTn 基线浓度低于非当前 snus 用户(hs-cTnI 中位数,1.7ng/L;Q1 到 Q3:1.6-2.3 与 2.0ng/L;Q1 到 Q3:1.6-3.2 [=0.020];hs-cTnT:中位数,2.9ng/L,Q1 到 Q3:2.9-3.5 与 2.9ng/L,Q1 到 Q3:2.9-4.3 [=0.021])。在完全调整的多变量模型中,鼻烟的使用与 hs-cTn 浓度从基线到 3 小时(hs-cTnI:-29%[=0.002],hs-cTnT:-18%[=0.010])和 24 小时(hs-cTnI:-30%[=0.010],hs-cTnT:-19%,[=0.013])的变化呈负相关。
与非使用者相比,当前使用无烟烟草者的静息 hs-cTn 浓度较低,运动引起的心肌肌钙蛋白反应减弱。需要进一步深入了解烟草使用者运动引起的肌钙蛋白反应减弱的病理生理过程。